Dani Stoltzfus
Corporate Officer/Principal presso NEUBASE THERAPEUTICS, INC.
Profilo
Dani Stoltzfus is currently working as Vice President-Research at NeuBase Therapeutics, Inc. She has an education background from Flinders University, where she completed her undergraduate, graduate, and doctorate degrees.
Posizioni attive di Dani Stoltzfus
| Società | Posizione | Inizio |
|---|---|---|
| NEUBASE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Dani Stoltzfus
| Flinders University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
NeuBase Therapeutics, Inc.
 NeuBase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NeuBase Therapeutics, Inc. is a biotechnology company, which engages in the development of drugs for patients with genetic neurological disorders. The firm’s therapies are built on a proprietary platform called PATrOL that encompasses a novel peptide-nucleic acid antisense oligonucleotide technology combined with novel delivery shuttles that overcome many of the hurdles to selective mutation engagement, repeat dosing, and systemic delivery of genetic medicines. The company was founded by Dietrich A. Stephan on August 4, 2009 and is headquartered in Pittsburgh, PA. | Health Technology |
- Borsa valori
- Insiders
- Dani Stoltzfus
